0 items USD 0.00Search
Your search for "chronic hepatitis C" gave back 6395 results.
The global Chronic Hepatitis B Oral Drugs market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at...
Catalog:
LPI
April 2024
Price: USD 3,660.00
The global Chronic Hepatitis B Oral Drugs market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast...
Catalog:
GIR
March 2024
Price: USD 4,480.00
The global Chronic Hepatitis B Oral Drugs market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030...
Catalog:
GIR
March 2024
Price: USD 3,480.00
The global Chronic Hepatitis B Treatment Drug market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The global Chronic Hepatitis C Drug market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The global Anti-Hepatitis C Drugs market size was valued at USD 2381 million in 2022 and is forecast to a readjusted size of USD 3519.6 million by...
Catalog:
GIR
December 2023
Price: USD 3,480.00
Hepatitis C is a contagious liver disease caused due to hepatitis C virus. Hepatitis C damages and infects the liver. Hepatitis C is spread as the...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
The global Anti-Hepatitis C Drugs market size was valued at US$ 2263.7 million in 2022. With growing demand in downstream market, the Anti-Hepatitis...
Catalog:
LPI
December 2023
Price: USD 3,660.00
It means a treatment of Hepatitis B—— contagious liver infection that can be long lasting. The global Hepatitis B Treatment market was valued at US$...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The global Human Hepatitis B Immunoglobulin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Treatment for chronic hepatitis B may include: Antiviral medications. Several antiviral medications — including entecavir (Baraclude), tenofovir (...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Hepatitis C is a contagious liver disease caused due to hepatitis C virus. Hepatitis C damages and infects the liver. Hepatitis C is spread as the...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
Over the recent years, the global Hepatitis B Treatment industry has been driven by the increasing number of patients diagnosed with Chronic...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Treatment for chronic hepatitis B may include: Antiviral medications. Several antiviral medications — including entecavir (Baraclude), tenofovir (...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
The main objective of hepatitis B immunization strategies is to prevent chronic hepatitis B virus infection and its serious consequences, including...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
